Pain and Inflammation Research

Although separate conditions, pain and inflammation are nearly always associated with each other. Pain is defined by the International Association for the Study of Pain (IASP) as 'an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage'. Inflammation is the tissue's immunologic response to injury, characterized by mobilization of white blood cells and antibodies, swelling, and fluid accumulation.

Pain and Inflammation Research Products Areas

Products for Pain and Inflammation Research - Page 54

Cat.No. Product Name Information/Activity
BCC7346 LY 320135 176977-56-3
BCC7852 MJ 15 944154-76-1
BCC7810 NIDA 41020 502486-89-7
BCC7746 PF 514273 851728-60-4
BCC7954 (±)-SLV 319 (±)-Ibipinabant ((±)-SLV319) is the racemate of SLV319. (±)-Ibipinabant ((±)-SLV319) is a potent and selective cannabinoid-1 (CB-1) receptor antagonist with an IC50 of 22 nM.
BCC1898 Rimonabant hydrochloride Rimonabant hHydrochloride (SR 141716A Hydrochloride) is a highly potent and selective central cannabinoid receptor (CB1) antagonist with an Ki of 1.8 nM. Rimonabant hHydrochloride (SR 141716A Hydrochloride) also inhibits Mycobacterial membrane protein Large 3 (MMPL3).
BCC6144 TC-C 14G 656804-72-7
BCC4411 Org 27569 Org 27569 is a potent CB1 receptor allosteric modulator, which increases agonist binding, yet blocks agonist-induced CB1 signaling.
BCC7401 Tocrifluor T1117 1186195-59-4
BCC5971 HU 308 Potent and selective CB<sub>2</sub> agonist